Literature DB >> 2904221

Clinical and molecular heterogeneity of phenylalanine hydroxylase deficiencies in France.

F Rey1, M Berthelon, C Caillaud, S Lyonnet, V Abadie, F Blandin-Savoja, J Feingold, J M Saudubray, J Frézal, A Munnich.   

Abstract

RFLPs of 68 normal and 74 mutant alleles at the phenylalanine hydroxylase (PAH) locus were determined in 37 French kindreds. A total of 23 haplotypes, including 18 normal and 16 mutant alleles, were observed. Two-thirds of all mutant alleles were confined within only four haplotypes, while the last third was accounted for by 12 haplotypes, including eight haplotypes absent from Caucasian pedigrees reported thus far. Several mutant haplotypes were present in typical phenylketonuria only, others were present in variants only, and some were present in both. In addition, a particular mutant haplotype (haplotype 2) was found to harbor different mutations in our series, resulting in either typical phenylketonuria or in mild hyperphenylalaninemias. The diploid combination of so many mutant haplotypes in PAH-deficient patients and of compound heterozygosity at the PAH locus in southern Europe might account for the broad spectrum of individual phenotypes observed in France.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2904221      PMCID: PMC1715615     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  18 in total

1.  Extensive restriction site polymorphism at the human phenylalanine hydroxylase locus and application in prenatal diagnosis of phenylketonuria.

Authors:  A S Lidsky; F D Ledley; A G DiLella; S C Kwok; S P Daiger; K J Robson; S L Woo
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

2.  Nucleotide sequence of a full-length complementary DNA clone and amino acid sequence of human phenylalanine hydroxylase.

Authors:  S C Kwok; F D Ledley; A G DiLella; K J Robson; S L Woo
Journal:  Biochemistry       Date:  1985-01-29       Impact factor: 3.162

3.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

4.  Kinetics of phenylalanine disappearance after intravenous load in phenylketonuria and its genetic variants.

Authors:  F Rey; F Blandin-Savoja; J Rey
Journal:  Pediatr Res       Date:  1979-01       Impact factor: 3.756

Review 5.  The mutation and polymorphism of the human beta-globin gene and its surrounding DNA.

Authors:  S H Orkin; H H Kazazian
Journal:  Annu Rev Genet       Date:  1984       Impact factor: 16.830

6.  Detection of phenylalanine hydroxylase messenger RNA in liver biopsy samples from patients with phenylketonuria.

Authors:  A G DiLella; F D Ledley; F Rey; A Munnich; S L Woo
Journal:  Lancet       Date:  1985-01-19       Impact factor: 79.321

7.  Tight linkage between a splicing mutation and a specific DNA haplotype in phenylketonuria.

Authors:  A G DiLella; J Marvit; A S Lidsky; F Güttler; S L Woo
Journal:  Nature       Date:  1986 Aug 28-Sep 3       Impact factor: 49.962

8.  Detection of hepatic phenylalanine 4-hydroxylase in classical phenylketonuria.

Authors:  P A Friedman; D B Fisher; E S Kang; S Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

9.  Compound heterozygotes in hyperphenylalaninaemia.

Authors:  K Bartholomé; K Olek; F Trefz
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

10.  Molecular analysis of the inheritance of phenylketonuria and mild hyperphenylalaninemia in families with both disorders.

Authors:  F D Ledley; H L Levy; S L Woo
Journal:  N Engl J Med       Date:  1986-05-15       Impact factor: 91.245

View more
  32 in total

1.  Linkage disequilibrium between phenylketonuria and RFLP haplotype 1 at the phenylalanine hydroxylase locus in Portugal.

Authors:  C Caillaud; L Vilarinho; A Vilarinho; F Rey; M Berthelon; R Santos; S Lyonnet; M L Briard; R V Osorio; J Rey
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

Review 2.  Heterogeneity of phenylketonuria at the clinical, protein and DNA levels.

Authors:  R G Cotton
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Single-strand conformation polymorphism for detection of mutations and base substitutions in phenylketonuria.

Authors:  P Labrune; D Melle; F Rey; M Berthelon; C Caillaud; J Rey; A Munnich; S Lyonnet
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

4.  Molecular heterogeneity at the phenylalanine hydroxylase locus in the population of the south-west of England.

Authors:  L A Tyfield; M J Osborn; J B Holton
Journal:  J Med Genet       Date:  1991-04       Impact factor: 6.318

Review 5.  Molecular genetics of phenylketonuria and its implications.

Authors:  H L Levy
Journal:  Am J Hum Genet       Date:  1989-11       Impact factor: 11.025

6.  Identification of the haplotype pattern associated with the mutant PKU allele in the Gypsy population of Wales.

Authors:  L A Tyfield; A L Meredith; M J Osborn; P S Harper
Journal:  J Med Genet       Date:  1989-08       Impact factor: 6.318

7.  Novel PKU mutation on haplotype 2 in French-Canadians.

Authors:  S W John; R Rozen; R Laframboise; C Laberge; C R Scriver
Journal:  Am J Hum Genet       Date:  1989-12       Impact factor: 11.025

8.  DNA haplotype analyses of patients with hyperphenylalaninemia.

Authors:  D Di Silvestre; A Pandya; R Koch; J Groffen
Journal:  Am J Hum Genet       Date:  1990-10       Impact factor: 11.025

9.  Haplotype distribution at the phenylalanine hydroxylase locus in PKU families from the Moravian area of Czechoslovakia.

Authors:  L Kozák; D Dvoráková; A Pijácková; J Kamarýt
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

10.  Phenylketonuria in Spain: RFLP haplotypes and linked mutations.

Authors:  L R Desviat; B Pérez; M Ugarte
Journal:  Hum Genet       Date:  1993-10-01       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.